Work

Time-dependent indirect comparison of enfortumab vedotin plus pembrolizumab and disitamab vedotin plus toripalimab in advanced urothelial carcinoma

Year: 2026

Type: article

Source: Journal of Chemotherapy

DOI: 10.1080/1120009x.2026.2751380

Authors: Hiroki Tanaka, Hiroshi Fukushima, Wei Chen, Fei Li, Soichiro Yoshida, Yasuhisa Fujii

Institutions: Institute of Science Tokyo, Nanfang Hospital, Southern Medical University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7224248447

FWCI:

Cites: 15

Cited by:

Related to: 10